50 – Overview of the cGCP Regulatory Landscape (S21E1)

Delve into the expansive regulatory framework that governs clinical trials. Discover the critical roles played by key agencies such as the FDA, EMA, and WHO, and understand how ICH guidelines, like ICH E6(R2), fit into the overall picture. We'll also explore the history and evolution of these regulations, tracing their origins and how they've adapted over time. This episode will highlight the interconnectedness of these regulations, revealing how they form a global system dedicated to ethical conduct, participant safety, and the generation of high-quality data in clinical research.

Journey through the key milestones that shaped today's landscape, from the 1906 Pure Food and Drug Act to the impactful thalidomide tragedy and the subsequent Kefauver-Harris Amendments. By examining these pivotal moments, we will understand the reasons behind strict clinical trial oversight, learning how regulatory agencies ensure that research is conducted ethically and scientifically. This podcast also emphasizes the importance of GCP, and we will discuss how data from clinical trials, along with protecting participants. Join us to navigate this complex world and to gain clarity on the essential elements that safeguard clinical research.